GlassScriptPhysician profile
Zoe D Varner
NPI 1013258243
$6,367.73
in general payments reported to CMS, 2019-2025
37 companies · $1,592 in 2025
The $1,592 reported for 2025 was more than what 88% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $590 · 2022: $1,270 · 2023: $1,543 · 2024: $1,373 · 2025: $1,592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,368 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,368.25 |
| Education | $139.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $622.69 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Sumitomo Pharma America, INC. | $609.01 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $443.88 | 2021-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $439.05 | 2021-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $386.63 | 2021-2025 | |
| Rochester Medical Corporation | $367.71 | 2021-2022 | |
| Pfizer INC. | $355.87 | 2022-2025 | |
| Boston Scientific Corporation | $351.66 | 2023-2024 | Rezum Generator, Spaceoar Vue System - 10ml |
| Myovant Sciences INC. | $207.30 | 2021-2022 | |
| Blue Earth Diagnostics | $200.69 | 2021-2024 | |
| Endo Pharmaceuticals INC. | $199.16 | 2021-2024 | Xiaflex, Aveed |
| Progenics Pharmaceuticals, INC. | $185.41 | 2023-2025 | Pylarify |
| Medtronic, INC. | $179.77 | 2022-2023 | Interstim |
| Abbvie INC. | $172.68 | 2021-2025 | |
| Urogen Pharma, INC. | $172.43 | 2023-2025 | Jelmyto |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $149.16 | 2023-2024 | |
| Urovant Sciences INC | $131.03 | 2022 | |
| Tempus Ai, INC | $120.47 | 2024 | Xt Cdx |
| Kowa Pharmaceuticals America, INC. | $118.23 | 2022 | |
| Caris Mpi, INC. | $108.30 | 2025 | Mi Cancer Seek |
| Tolmar Pharmaceuticals, INC. | $101.35 | 2021-2022 | |
| 180 Medical, INC. | $100.69 | 2022-2023 | Magic3 Intermittent Catheter, Gentlecath |
| Dendreon Pharmaceuticals LLC | $84.41 | 2025 | Provenge |
| Antares Pharma, INC. | $84.04 | 2022-2023 | Xyosted, Nocdurna, Tlando |
| Endo USA, INC. | $83.92 | 2024-2025 | Xiaflex, Aveed |
| Teleflex LLC | $82.55 | 2024-2025 | Urolift, Barrigel |
| Accord Healthcare, INC. | $54.21 | 2025 | |
| Immunitybio, INC. | $41.36 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Procept Biorobotics Corporation | $30.97 | 2025 | |
| Merck Sharp & Dohme LLC | $28.71 | 2025 | Keytruda |
| Telix Pharmaceuticals | $25.10 | 2024 | Illuccix |
| Abc Home Medical Supply, INC. | $23.09 | 2023 | |
| Dentsply Ih Ab | $20.68 | 2024 | Lofric |
| Novartis Pharmaceuticals Corporation | $19.50 | 2025 | |
| Angiodynamics, INC. | $17.58 | 2023 | Nanoknife |
| Myriad Genetic Laboratories, INC. | $13.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zoe Varner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.